14.55
Kala Bio Inc Borsa (KALA) Ultime notizie
Is KALA BIO Inc. a candidate for recovery playQuarterly Profit Review & Risk Adjusted Buy and Sell Alerts - Newser
What data driven models say about KALA BIO Inc.’s futureBuy Signal & Reliable Price Breakout Signals - Newser
Technical analysis overview for KALA BIO Inc. stockJuly 2025 Outlook & Weekly Top Gainers Alerts - Newser
KALA BIO Inc. stock trend forecastMarket Weekly Review & AI Powered Buy/Sell Recommendations - Newser
Can KALA BIO Inc. outperform under higher oil pricesPortfolio Risk Report & Daily Profit Focused Screening - beatles.ru
What drives KALA BIO Inc.’s stock pricePortfolio Value Summary & Growth-Oriented Investment Plans - خودرو بانک
Can KALA BIO Inc. weather a recessionJuly 2025 Update & Risk Controlled Swing Trade Alerts - خودرو بانک
Is KALA BIO Inc. forming bullish engulfing patternsQuarterly Profit Summary & Daily Technical Stock Forecast Reports - خودرو بانک
Q3 Earnings Forecast for KALA BIO Issued By Lifesci Capital - Defense World
Will KALA BIO Inc. stock go up soon2025 Momentum Check & Risk Controlled Stock Pick Alerts - Newser
Can KALA BIO Inc. disrupt its industryDollar Strength & Real-Time Stock Price Movement Reports - خودرو بانک
Visual trend scoring systems applied to KALA BIO Inc.Weekly Profit Report & Community Driven Trade Alerts - Newser
How to read the order book for KALA BIO Inc.Dip Buying & Reliable Entry Point Alerts - Newser
Individual investors are KALA BIO, Inc.'s (NASDAQ:KALA) biggest owners and were rewarded after market cap rose by US$28m last week - simplywall.st
KALA BIO, Inc.'s (NASDAQ:KALA) market cap surged US$28m last week, retail investors who have a lot riding on the company were rewarded - Yahoo Finance
What’s KALA BIO Inc.’s historical returnJuly 2025 Highlights & Safe Entry Point Identification - خودرو بانک
Is KALA BIO On The Verge Of A Pivotal Moment With KPI-012? - RTTNews
Smart tools for monitoring KALA BIO Inc.’s price action2025 Risk Factors & AI Forecasted Entry and Exit Points - Newser
Is KALA BIO Inc. showing insider buyingPortfolio Update Summary & Entry Point Confirmation Alerts - 더경남뉴스
Using Python tools to backtest KALA BIO Inc. strategies2025 Winners & Losers & Verified Technical Signals - Newser
Can you recover from losses in KALA BIO Inc.July 2025 Gainers & Technical Pattern Based Buy Signals - Newser
What’s next for KALA BIO Inc. stock priceWeekly Stock Report & Low Drawdown Investment Strategies - Newser
Signal strength of KALA BIO Inc. stock in tech scannersMarket Activity Recap & AI Optimized Trade Strategies - Newser
KALA BIO to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
Using data tools to time your KALA BIO Inc. exitWeekly Trend Recap & Short-Term Swing Trade Alerts - Newser
Rare Eye Disease Biotech KALA BIO to Present Latest Developments at H.C. Wainwright Conference - Stock Titan
Momentum divergence signals in KALA BIO Inc. chartJuly 2025 Action & Risk Managed Trade Strategies - Newser
KALA BIO Inc.’s volatility index tracking explainedJuly 2025 PostEarnings & Advanced Swing Trade Entry Plans - Newser
What candlestick patterns are forming on KALA BIO Inc.Weekly Loss Report & High Conviction Trade Alerts - Newser
What’s the analyst consensus on KALA BIO Inc.2025 Price Action Summary & Long-Term Capital Growth Ideas - خودرو بانک
Can KALA BIO Inc. continue delivering strong returns2025 Valuation Update & Trade Opportunity Analysis - خودرو بانک
KALA BIO Promotes President And COO Todd Bazemore To President And CEO - Nasdaq
Kala Bio appoints Todd Bazemore as CEO and director, updates compensation - Investing.com
KALA BIO Appoints Todd Bazemore as President, Chief Executive Officer and Director - The Manila Times
Rare Disease Expert Todd Bazemore Takes Helm at KALA BIO Ahead of Crucial Phase 2b Trial Results - Stock Titan
KALA BIO Soars 12.75% on CHASE Trial Anticipation - AInvest
Statistical indicators supporting KALA BIO Inc.’s strengthWeekly Trade Recap & High Return Trade Opportunity Guides - Newser
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):